Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CSS INDUSTRIES INCCSS · Entity 150987 | Exec. VP and CFO | May 29, 2019 | May 31, 2019 |
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director · President, CEO | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CSS INDUSTRIES INC
Report date May 29, 2019 · Filed May 31, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock ($.10 par value)SEC Table I · non-derivative | Direct | 2,851 |
Ending reported balance
After 2019-05-31 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2019-05-29 · Exercise / conversion · Acquired 687 · Balance 2,678 F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. Row 2 · 2019-05-29 · Tax withholding · Disposed 189 · Balance 2,489 F2: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. Row 3 · 2019-05-31 · Exercise / conversion · Acquired 500 · Balance 2,989 F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. Row 4 · 2019-05-31 · Tax withholding · Disposed 138 · Balance 2,851 F2: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,063 |
Reported balance
After 2019-05-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-05-29 · Exercise / conversion · Disposed 687 · Balance 2,063 F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. F3: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 500 |
Reported balance
After 2019-05-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-05-31 · Exercise / conversion · Disposed 500 · Balance 500 F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. F4: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.
F2: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.
F3: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.
F4: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 100,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 100,000 · Balance 100,000 F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2026 Filed Jan 23, 2026 22:10 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021263 · ownership.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter. Read SEC document |
| July 18, 2025 Filed Aug 27, 2025 22:10 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $56.34 | $0.00 |
DisclosureSEC source: 0000950170-25-111762 · ownership.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2035-07-18 F1 · derivative.exercise_date: These options were granted on July 18, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 18, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 23:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 60,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047033 · ownership.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 8,334 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0000950170-25-005353 · ownership.xml · derivative · entry 6 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 833 Underlying: Class A Common Stock · 8,334 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,833 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0000950170-25-005353 · ownership.xml · derivative · entry 5 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,833 shares Expires 2029-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on September 3, 2019 and are fully vested. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 1,666 | $89.17 | $148,557.22 |
DisclosureSEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 4 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 15, 2023 executed by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.69 to $89.63, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 12,501 | $88.17 | $1,102,213.17 |
DisclosureSEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 3 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,666 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 15, 2023 executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.60 to $88.55, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 8,334 | $53.27 | $443,952.18 |
DisclosureSEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:12 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,833 | $49.65 | $289,608.45 |
DisclosureSEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · COO, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 60,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008889 · ownership.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| October 10, 2023 Filed Oct 19, 2023 21:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 5,000 | $0.00 Strike: $53.02 | $0.00 |
DisclosureSEC source: 0001209191-23-053189 · doc4.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Class A Common Stock · 5,000 shares Expires 2033-09-01 F1 · derivative.exercise_date: These options were granted on October 10, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-23-007323 · doc4.xml · derivative · entry 5 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,167 Underlying: Class A Common Stock · 15,000 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 14,167 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001209191-23-007323 · doc4.xml · derivative · entry 4 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,833 Underlying: Class A Common Stock · 14,167 shares Expires 2029-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on September 3, 2019 and are fully vested. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 29,167 | $77.57 | $2,262,425.86 |
DisclosureSEC source: 0001209191-23-007323 · doc4.xml · nonDerivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.885, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 15,000 | $53.27 | $799,050.00 |
DisclosureSEC source: 0001209191-23-007323 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 14,167 | $49.65 | $703,391.55 |
DisclosureSEC source: 0001209191-23-007323 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 21:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013219 · doc4.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005586 · doc4.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 20:41 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 833 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-21-052968 · doc4.xml · derivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,334 Underlying: Class A Common Stock · 833 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 20:41 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 833 | $76.13 | $63,416.29 |
DisclosureSEC source: 0001209191-21-052968 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 20:41 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 833 | $53.27 | $44,373.91 |
DisclosureSEC source: 0001209191-21-052968 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 0 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-23-007310 · doc4a.xml · derivative · entry 4 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,167 Underlying: Class A Common Stock · 0 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. F4 · balance_after: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019. Read SEC document |
| August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 833 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001209191-23-007310 · doc4a.xml · derivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 833 shares Expires 2029-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65. F3 · derivative.exercise_date: These options were granted on September 3, 2019 and are fully vested. F4 · balance_after: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019. Read SEC document |
| August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 833 | $76.13 | $63,416.29 |
DisclosureSEC source: 0001209191-23-007310 · doc4a.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 833 | $49.65 | $41,358.45 |
DisclosureSEC source: 0001209191-23-007310 · doc4a.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 22:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 833 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-21-049452 · doc4.xml · derivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,167 Underlying: Class A Common Stock · 833 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 22:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 833 | $83.24 | $69,338.92 |
DisclosureSEC source: 0001209191-21-049452 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.24 to $83.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 22:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 833 | $53.27 | $44,373.91 |
DisclosureSEC source: 0001209191-21-049452 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 20:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 834 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001209191-21-047369 · doc4.xml · derivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,833 Underlying: Class A Common Stock · 834 shares Expires 2029-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 20:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 834 | $78.25 | $65,260.50 |
DisclosureSEC source: 0001209191-21-047369 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 20:20 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 834 | $49.65 | $41,408.10 |
DisclosureSEC source: 0001209191-21-047369 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 833 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-21-045571 · doc4.xml · derivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 833 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 833 | $77.43 | $64,499.19 |
DisclosureSEC source: 0001209191-21-045571 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:14 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 833 | $53.27 | $44,373.91 |
DisclosureSEC source: 0001209191-21-045571 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 20:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 14,167 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-21-043495 · doc4.xml · derivative · entry 5 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,833 Underlying: Class A Common Stock · 14,167 shares Expires 2030-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 20:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 13,312 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001209191-21-043495 · doc4.xml · derivative · entry 4 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,667 Underlying: Class A Common Stock · 13,312 shares Expires 2029-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 20:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 27,479 | $75.04 | $2,062,024.16 |
DisclosureSEC source: 0001209191-21-043495 · doc4.xml · nonDerivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 20:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 14,167 | $53.27 | $754,676.09 |
DisclosureSEC source: 0001209191-21-043495 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 20:52 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 13,312 | $49.65 | $660,940.80 |
DisclosureSEC source: 0001209191-21-043495 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:17 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 5,021 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001209191-21-030906 · doc4.xml · derivative · entry 3 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,979 Underlying: Class A Common Stock · 5,021 shares Expires 2029-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:17 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 5,021 | $75.00 | $376,575.00 |
DisclosureSEC source: 0001209191-21-030906 · doc4.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:17 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 5,021 | $49.65 | $249,292.65 |
DisclosureSEC source: 0001209191-21-030906 · doc4.xml · nonDerivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:48 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004036 · doc4.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:42 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004852 · doc4.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:57 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001209191-19-048566 · doc4.xml · derivative · entry 1 Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2029-09-03 F1 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 31, 2019 Filed May 31, 2019 16:27 UTC | CSS INDUSTRIES INC CSS · Entity 150987 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · derivative · entry 6 Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock ($.10 par value) · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. F4 · derivative.exercise_date: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis. F4 · derivative.expiration_date: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis. Read SEC document |
| May 31, 2019 Filed May 31, 2019 16:27 UTC | CSS INDUSTRIES INC CSS · Entity 150987 | Tax withholdingCommon Stock ($.10 par value) | 138 | $6.15 | $848.70 |
DisclosureSEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · nonDerivative · entry 4 Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,851 F2 · kind: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. Read SEC document |
| May 31, 2019 Filed May 31, 2019 16:27 UTC | CSS INDUSTRIES INC CSS · Entity 150987 | Exercise / conversionCommon Stock ($.10 par value) | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · nonDerivative · entry 3 Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. Read SEC document |
| May 29, 2019 Filed May 31, 2019 16:27 UTC | CSS INDUSTRIES INC CSS · Entity 150987 | Exercise / conversionRestricted Stock Units · Derivative | 687 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · derivative · entry 5 Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063 Underlying: Common Stock ($.10 par value) · 687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock. F3 · derivative.exercise_date: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis. F3 · derivative.expiration_date: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis. Read SEC document |
| May 29, 2019 Filed May 31, 2019 16:27 UTC | CSS INDUSTRIES INC CSS · Entity 150987 | Tax withholdingCommon Stock ($.10 par value) | 189 | $6.28 | $1,186.92 |
DisclosureSEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · nonDerivative · entry 2 Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,489 F2 · kind: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.